cr 1392 has been researched along with sincalide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Fujii, M; Fujisawa, T; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 1 |
| Bani, M; Chisté, R; Makovec, F; Revel, L; Rovati, LA; Rovati, LC | 1 |
2 other study(ies) available for cr 1392 and sincalide
| Article | Year |
|---|---|
Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Topics: Amylases; Animals; Cholecystokinin; Dose-Response Relationship, Drug; Glutamine; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Sincalide | 1989 |
Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
Topics: Animals; Benzamides; Cerebral Cortex; In Vitro Techniques; Kinetics; Male; Mice; Pancreas; Proglumide; Rats; Receptors, Cell Surface; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1986 |